[HTML][HTML] Final results of a prospective evaluation of the predictive value of interim positron emission tomography in patients with diffuse large B-cell lymphoma treated …
Our main objective was to prospectively determine the prognostic value of [(18) F]
fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) after …
fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) after …
Myeloid neoplasms post PARP inhibitors for ovarian cancer
G Caruso, F Gigli, G Parma, M Lapresa… - International Journal of …, 2023 - ijgc.bmj.com
The incidence of myeloid neoplasms following treatment with poly (ADP-ribose) polymerase
inhibitors (PARPi) in patients with ovarian cancer has been gradually increasing over the …
inhibitors (PARPi) in patients with ovarian cancer has been gradually increasing over the …
AVALON: The Italian cohort study on real‐life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid …
E Todisco, C Papayannidis, N Fracchiolla, E Petracci… - Cancer, 2023 - Wiley Online Library
Background Venetoclax in combination with hypomethylating agents (HMA) is
revolutionizing the therapy of acute myeloid leukemia (AML). However, evidence on large …
revolutionizing the therapy of acute myeloid leukemia (AML). However, evidence on large …
[HTML][HTML] Crosslinked Chitosan binder for sustainable aqueous batteries
The increased percentage of renewable power sources involved in energy production
highlights the importance of developing systems for stationary energy storage that satisfy the …
highlights the importance of developing systems for stationary energy storage that satisfy the …
A single dose of Pegfilgrastim versus daily Filgrastim to evaluate the mobilization and the engraftment of autologous peripheral hematopoietic progenitors in malignant …
S Bassi, C Rabascio, L Nassi, S Steffanoni… - … and Apheresis Science, 2010 - Elsevier
Pegfilgrastim has equivalent efficacy to daily G-CSF in enhancing neutrophil recovery after
chemotherapy, but conclusive data concerning its use for peripheral blood stem cell (PBSC) …
chemotherapy, but conclusive data concerning its use for peripheral blood stem cell (PBSC) …
Hematological disorders after salvage PARPi treatment for ovarian cancer: Cytogenetic and molecular defects and clinical outcomes
E Todisco, F Gigli, C Ronchini, V Amato… - … Journal of Cancer, 2022 - Wiley Online Library
Inhibitors of poly (ADP‐ribose) polymerase (PARPi) are increasingly employed as salvage
therapy in epithelial ovarian cancer (EOC), but cytotoxic drug exposure along with PARP …
therapy in epithelial ovarian cancer (EOC), but cytotoxic drug exposure along with PARP …
Early stage gastric diffuse large B-cell lymphomas: results of a randomised trial comparing chemotherapy alone versus chemotherapy + involved field radiotherapy
G Martinelli, F Gigli, L Calabrese, PF Ferrucci… - Leukemia & …, 2009 - Taylor & Francis
Here, we present the results of a randomised clinical trial carried out between 1998 and
2004, evaluating the possible role of radiotherapy (RT) as consolidation treatment after …
2004, evaluating the possible role of radiotherapy (RT) as consolidation treatment after …
Gimema ALL2418: interim analysis of a phase Iia study of feasibility and effectiveness of Inotuzumab Ozogamicin in adult patients with B-Cell Acute Lymphoblastic …
G Marconi, A Piciocchi, S Chiaretti, C Papayannidis… - Blood, 2022 - ashpublications.org
Background: Persistence of minimal residual disease (MRD) is associated with a high rate of
treatment failure, relapse, and death in B-cell acute lymphoblastic leukemia (B-ALL) …
treatment failure, relapse, and death in B-cell acute lymphoblastic leukemia (B-ALL) …
[HTML][HTML] Multicenter experience using total lymphoid irradiation and antithymocyte globulin as conditioning for allografting in hematological malignancies
G Messina, L Giaccone, M Festuccia, G Irrera… - Biology of Blood and …, 2012 - Elsevier
A non myeloablative conditioning with total lymphoid irradiation (TLI) and antithymocyte
globulin (ATG) was shown to protect against graft-versus-host disease (GVHD). To evaluate …
globulin (ATG) was shown to protect against graft-versus-host disease (GVHD). To evaluate …
Antibodies against human cytomegalovirus late protein UL94 in the pathogenesis of scleroderma-like skin lesions in chronic graft-versus-host disease
R Pastano, C Dell'Agnola, C Bason… - International …, 2012 - academic.oup.com
Human cytomegalovirus (hCMV) infection and its reactivation correlate both with the
increased risk and with the worsening of graft-versus-host disease (GVHD). Because …
increased risk and with the worsening of graft-versus-host disease (GVHD). Because …